Indian Drug Makers Hit By Sharp Increase In Chinese Antibiotics Element
This article was originally published in PharmAsia News
Indian drug makers are seriously concerned about a recent sharp increase in the price of imported penicillin-G, a key element in major antibiotics. Pen-G is imported from China by Indian pharmas at the rate of 500 tons a year just for domestic needs for antibiotics. Bulk Drug Manufacturers Association President M. Narayana Reddy said the recent increase was the largest for Pen-G during the past five years of price volatility. He said he did not know the cause of the increase, but mentioned "possible cartelling by the Chinese exporters." (Click here for more
You may also be interested in...
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
From enforced detention to hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.